Hypnotics use in children 0–18 months: moderate agreement between mother-reported survey data and prescription registry data

References

• Hartz I, Furu K, Bratlid T, Handal M, Skurtveit S. Hypnotic drug use among 0-17 year olds during 2004-2011: a nationwide prescription database study. Scand J Public Health. 2012;40(8):704–711.
   PubMed Web of Science ®Google Scholar
• Stojanovski SD, Rasu RS, Balkrishnan R, Nahata MC. Trends in medication prescribing for pediatric sleep difficulties in US outpatient settings. Sleep. 2007;30(8):1013–1017.
   PubMed Web of Science ®Google Scholar
• Heussler H, Chan P, Price AM, Waters K, Davey MJ, Hiscock H. Pharmacological and non-pharmacological management of sleep disturbance in children: an Australian paediatric research network survey. Sleep Med. 2013;14(2):189–194.
   PubMed Web of Science ®Google Scholar
• Owens JA, Rosen CL, Mindell JA. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics. 2003;111 (5 Pt 1):e628–e635.
   PubMed Web of Science ®Google Scholar
• Sorensen E. Sleep disorders in children and adolescents. Tidsskr Nor Laegeforen. 2009;129(19):2000–2003.
   PubMedGoogle Scholar
• Holdo I, Handal M, Skurtveit S, Bramness JG. Association between prescribing hypnotics for parents and children in Norway. Arch Dis Child. 2013;98(9):732–736.
   PubMed Web of Science ®Google Scholar
• Slordal L, Bramness JG. Is alimemazine a suitable sleeping agent for children? Tidsskr Nor Laegeforen. 2008;128(19):2194–2196.
   PubMedGoogle Scholar
• Sanz EJ. Drug prescribing for children in general practice. Acta Paediatr. 1998;87(5):489–490.
   PubMed Web of Science ®Google Scholar
• Lissauer T, Clayden G. Illustrated textbook of paediatrics, vol.2ndEdinburgh: Mosby; 2001
   Google Scholar
• West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol. 1995;142(10):1103–1112.
   PubMed Web of Science ®Google Scholar
• Furu K, Karlstad O, Skurtveit S, Haberg SE, Nafstad P, London SJ, Nystad W. High validity of mother-reported use of antiasthmatics among children: a comparison with a population-based prescription database. J Clin Epidemiol. 2011;64(8):878–884.
   PubMed Web of Science ®Google Scholar
• Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C. Cohort profile: the Norwegian mother and child cohort study (MoBa). Int J Epidemiol. 2006;35(5):1146–1150.
   PubMed Web of Science ®Google Scholar
• Magnus P, Birke C, Vejrup K, Haugan A, Alsaker E, Daltveit AK, Handal M, Haugen M, Hoiseth G, Knudsen GP, et al. Cohort profile update: the Norwegian mother and child cohort study (MoBa). Int J Epidemiol. 2016;45(2):382–388.
   PubMed Web of Science ®Google Scholar
• Questionnaires from MoBa [https://www.fhi.no/en/studies/moba/for-forskere-artikler/questionnaires-from-moba/]. Accessed 13 June 2016.
   Google Scholar
• Irgens LM. The medical birth registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand. 2000;79(6):435–439.
   PubMed Web of Science ®Google Scholar
• Furu K. Establishment of the nationwide Norwegian prescription database (NorPD) - new opportunities for research in pharmacoepidemiology in Norway. Nor Epidemiol. 2008;18(2):129–136
   Google Scholar
• Rønning M, Berg C, Furu K, Litleskare I, Sakshaug S, Selmer R, Skurtveit S, Strøm H. Reseptregisteret 2005-2009. Tema: Vanedannende legemidler, Folkehelseinstituttet. Statistikk 2010. ISBN: 978-82-8082-409-7, ISBN (elektronisk): 978-82-8082-408-0, ISSN: .
   Google Scholar
• Generell veileder i pediatri [http://www.helsebiblioteket.no/retningslinjer/pediatri/forside]. Accessed 01 Aug 2015.
   Google Scholar
• Fleiss JL. Statistical methods for rates and proportions. 2nd. New York:Wiley; 1981
   Google Scholar
• Sabaté E. Adherence to long-term therapies : evidence for action. Geneva: World Health Organization; 2003.
   Google Scholar
• Bulloch AG, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol. 2010;45(1):47–56.
   PubMed Web of Science ®Google Scholar
• West SL, Ritchey ME, Poole C. Validity of Pharmacoepidemiologic drug and diagnosis data. In: Pharmacoepidemiology. Oxford: Wiley-Blackwell; 2012. p. 757–94.
   Google Scholar
• Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden - assessed by the prescribed drug register and the medical birth register. Clin Epidemiol. 2011;3:43–50.
   PubMedGoogle Scholar
• Nielsen MW, Sondergaard B, Kjoller M, Hansen EH. Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. J Clin Epidemiol. 2008;61(9):919–924.
   PubMed Web of Science ®Google Scholar
• Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf. 2002;11(5):379–384.
   PubMed Web of Science ®Google Scholar
• Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol. 1986;123(4):670–676.
   PubMed Web of Science ®Google Scholar
• Skurtveit S, Selmer R, Tverdal A, Furu K. The validity of self-reported prescription medication use among adolescents varied by therapeutic class. J Clin Epidemiol. 2008;61(7):714–717.
   PubMed Web of Science ®Google Scholar
• Pisa FE, Casetta A, Clagnan E, Michelesio E, Vecchi Brumatti L, Barbone F. Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort. BMC Pregnancy Childbirth. 2015;15:310.
   PubMed Web of Science ®Google Scholar
• Grimaldi-Bensouda L, Rossignol M, Aubrun E, El Kerri N, Benichou J, Abenhaim L. Agreement between patients’ self-report and physicians’ prescriptions on cardiovascular drug exposure: the PGRx database experience. Pharmacoepidemiol Drug Saf. 2010;19(6):591–595.
   PubMed Web of Science ®Google Scholar
• Sarangarm P, Young B, Rayburn W, Jaiswal P, Dodd M, Phelan S, Bakhireva L. Agreement between self-report and prescription data in medical records for pregnant women. Birth Defects Res A Clin Mol Teratol. 2012;94(3):153–161.
   PubMedGoogle Scholar
• West SL, Savitz DA, Koch G, Sheff KL, Strom BL, Guess HA, Hartzema AG. Demographics, health behaviors, and past drug use as predictors of recall accuracy for previous prescription medication use. J Clin Epidemiol. 1997;50(8):975–980.
   PubMed Web of Science ®Google Scholar
• Stolley PD, Tonascia JA, Sartwell PE, Tockman MS, Tonascia S, Rutledge A, Schinnar R. Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am J Epidemiol. 1978;107(3):226–235.
   PubMed Web of Science ®Google Scholar
• Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12(4):461–466.
   PubMed Web of Science ®Google Scholar
• Radin RG, Mitchell AA, Werler MM. Predictors of recall certainty of dates of analgesic medication use in pregnancy. Pharmacoepidemiol Drug Saf. 2013;22(1):25–32.
   PubMed Web of Science ®Google Scholar
• Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, Alsaker ER, Haug K, Daltveit AK, Magnus P. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol. 2009;23(6):597–608.
   PubMed Web of Science ®Google Scholar
• Skurtveit S, Selmer R, Odsbu I, Handal M. Self-reported data on medicine use in the Norwegian mother and child cohort study compared to data from the Norwegian prescription database. Nor Epidemiol. 2014;24(1–2):209–16.
   Google Scholar
• Furu KSS, Rosvold EO. Drug use questions in Norwegian health surveys – response rate and agreement between specific and open-ended questions. Nor Epidemiol. 2003;13(1):147–154
   Google Scholar